ArticlePloS one2014

ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.

Hekun Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.